Sermorelin
GHRH(1-29) analog
A 29-amino-acid fragment analog representing the biologically active region of growth hormone-releasing hormone (GHRH(1-29)), among the earliest GHRH analogs studied in growth-hormone-axis research and a reference compound against which newer analogs like CJC-1295 are typically compared.
What researchers are studying Sermorelin for.
Ghrh-Receptor Agonism
Gh-Axis Reference-Compound Research
Body-Composition Research
GHRH(1-29) analog — full 29-residue sequence via certificate of analysis
Concentration and unit math, worked out.
Worked example for a 5mg vial reconstituted with 3mL of bacteriostatic water, drawn on a U-100 insulin syringe. Use the calculator below for any other vial size or water volume.
| UNITS DRAWN | VOLUME | DELIVERS |
|---|---|---|
| 5 units | 0.05 mL | 83 mcg |
| 10 units | 0.10 mL | 167 mcg |
| 20 units | 0.20 mL | 333 mcg |
| 30 units | 0.30 mL | 500 mcg |
| 50 units | 0.50 mL | 833 mcg |
Run your own numbers.
Pre-filled with a 30-day starting point — one vial, dosed once daily for 30 days. Adjust any field to match your own protocol.
RESULTS
Educational reference tool only — not medical advice. Reconstitution and dosing decisions for any research protocol should be reviewed with a qualified professional. Figures assume uniform mixing and standard syringe calibration; always verify against your own protocol.